Proteomics: A discovery strategy for novel cancer biomarkers

Nature Reviews Cancer

Volumn 10, Issue 9, 2010, Pages 597-

  Swami, Meera ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1 INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN SERINE THREONINE KINASE INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; ENZYME PHOSPHORYLATION; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 77955966904     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2922     Document Type: Article

References (2)

1. Andersen, J. N. et al. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors. Sci. Trans. Med. 2, 43a55 (2010)
2. Kolch, W. & Pitt, A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nature Rev. Cancer 10, 618-629 (2010).